SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE518.203.9 (+0.76 %)
PREV CLOSE ( ) 514.30
OPEN PRICE ( ) 515.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 518.20 (93)
VOLUME 121379
TODAY'S LOW / HIGH ( )515.55 524.00
52 WK LOW / HIGH ( )433.15 728.45
NSE518.353.95 (+0.77 %)
PREV CLOSE( ) 514.40
OPEN PRICE ( ) 518.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 518.35 (6183)
VOLUME 3053990
TODAY'S LOW / HIGH( ) 515.90 524.00
52 WK LOW / HIGH ( )432.7 729.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
27Nov Sun Pharma, GPT Infraprojects and Cupi
Sun Pharmaceutical Industries’ US-based subsidiary -- Sun Pharmaceutical..
25Nov Sun Pharma’s arm recalls diabetes drug
Sun Pharmaceutical Industries’ US- based subsidiary -- Sun Pharmaceutica..
16Nov Sun Pharmaceutical advances on receivi
Sun Pharmaceutical Industries is currently trading at Rs. 508.00, up by..
15Nov Sun Pharma gets nod for scheme of arra
Sun Pharmaceutical Industries has received an approval for the Scheme of..
26Oct Sun Pharma’s arm receives USFDA approv
Sun Pharmaceutical Industries’ wholly owned subsidiary has received fina..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit5770.5-349.5
Gross Profit 5736.3 -324.4
Operating Profit 8082.96096.8
Net Sales 18238.478067
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2372.00 (2.52%)
M.Cap (Rs. in Cr)39348.46
Merck (BSE)
 1211.35 (2.65%)
M.Cap (Rs. in Cr)2010.77
Torrent Pharma (BSE)
 1342.95 (2.13%)
M.Cap (Rs. in Cr)22725.77
Zandu Realty (BSE)
 1994.40 (1.39%)
M.Cap (Rs. in Cr)160.83
Pfizer (BSE)
 1995.70 (1.17%)
M.Cap (Rs. in Cr)9129.87
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 13.57%
FI/BANKS/INSURANCE 7.17%
MUTUAL FUNDS/UTI 6.55%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.